Inmode Ltd stock is traded at $14.20, with a volume of 807,200. It is up +0.85% in the last 24 hours and up +0.50% over the past month. InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Previous Close:
$14.08
Open:
$14.18
24h Volume:
807,200
Relative Volume:
1.28
Market Cap:
$817.13M
Revenue:
$374.64M
Net Income/Loss:
$87.19M
P/E Ratio:
10.40
EPS:
$1.37
Net Cash Flow:
$90.65M
1W Performance:
+5.11%
1M Performance:
+0.50%
6M Performance:
-1.39%
1Y Performance:
-2.27%
1-Day Range:
$0.00$0.00
1-Week Range:
$13.19$14.54
52-Week Range:
$12.72$16.67
Inmode Ltd Stock (INMD) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS